Table 1.
Clinical characteristics of the participating patients in this study
Features | Total | AKAP4 | P | |
---|---|---|---|---|
|
||||
Low | High | |||
Median Age (Range) | 63.5 (42-77) | 64.5 (43-77) | 61.5 (42-74) | 0.338 |
Gender | 1 | |||
Male/Female | 22/8 | 11/4 | 11/4 | |
Stage | 0.696 | |||
I+II | 14 | 8 | 6 | |
III+IV | 16 | 8 | 8 | |
Lymph node status | 0.028 | |||
Negative | 16 | 11 | 5 | |
Positive | 14 | 4 | 10 | |
AKAP4 mRNA expression | 0.000 | |||
Low | 15 | 15 | 0 | |
High | 15 | 0 | 15 |